Geron (GERN) Stock Price
$1.31 4.4%
to add to portfolio
AI Score

-
Alternative
7 -
Fundamental
2 -
Technical
3
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Geron, AI stock picks, stock alerts and much more.
GERN AI Stock Analysis
AI stock analysis for GERN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Geron (GERN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Geron (GERN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Geron (GERN), currently trading at $1.31, will... Sign up to access price prediction.
About GERN

-
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies.
-
Symbol
GERN
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
832.6M
Similar Stocks
![]() |
Catalyst Pharmaceuticals CPRX |
$20.23 0.8% |
8 |
![]() |
Inovio Pharmaceuticals INO |
$2.22 2.7% |
2 |
![]() |
Moderna MRNA |
$24.93 0.3% |
4 |
![]() |
Anavex Life Sciences AVXL |
$8.82 1.5% |
5 |
![]() |
BridgeBio Pharma BBIO |
$51.55 0.1% |
6 |
News
GERN Alternative Data
Web Traffic
Geron receives an estimated 18456 monthly visitors to geron.com.
-
Web Traffic
18456
-
Change from Previous Month
52.3%
-
3 Month Change
62.4%
-
YoY Change
62.4%
LinkedIn Followers
20,612 are following Geron on LinkedIn, up by 1.9% over the last month.
-
LinkedIn Followers
20612
-
Daily Change
0%
-
1 Month Change
1.9%
-
3 Month Change
11.9%
-
YoY Change
11.9%
Job Postings
Geron has an estimated 7 open job postings, which is down -36.4% over the last month.
-
Job Postings
7
-
Daily Change
0%
-
1 Month Change
36.4%
-
3 Month Change
75%
-
YoY Change
75%
LinkedIn Employees
According to LinkedIn, Geron has 412 employees, up by 1.2% over the last month.
-
LinkedIn Employees
412
-
Daily Change
0%
-
1 Month Change
1.2%
-
3 Month Change
5.4%
-
YoY Change
5.4%
Reddit Mentions
Geron has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Geron is 49 out of 100 (neutral).
-
Business Outlook
49
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Sentiment
The sentiment Score for Geron is 67 out of 100, which represents a bullish sentiment.
-
Reddit Sentiment
66.6667
-
Daily Change
17.7%
-
1 Month Change
0%
News Mentions
Geron was mentioned 5 times in the news yesterday.
-
News Mentions
5
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
GERN Financials
GERN Key Metrics
-
Total Revenue
$47.5M
-
Net Income
-$25.4M
-
Earnings per Share
-$0.0392
-
Free cash flow
-$43.8M
-
EBITDA
-$16.3M
-
EBITDA Ratio
-0.343522
-
Total Assets
$593.8M
GERN 2-year Revenue & Income
GERN 2-year Free Cash Flow
GERN Technicals
GERN SMA
GERN RSI
FAQ
What's the current price of Geron (GERN) Stock?
The price of an Geron (GERN) share is $1.31.
What's the market cap of Geron?
The current market cap of Geron is 832.6M.
What are some stocks similar to Geron (GERN) that investors often compare it to?
Geron (GERN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Geron's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Geron's stock price to be around $1.25 in 2026. Starting from the current price of $1.31, this represents a 4.6% change in price, indicating a bearish outlook for the stock.
How to buy Geron (GERN) Stock?
Geron stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Geron shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.